Tokyo Guidelines 2018 for Acute Cholecystitis
ورودیهای بالینی بیمار
پارامترهای بالینی بیمار را در فرم روبرو وارد کنید و روی «محاسبه» کلیک نمایید تا نمره، طبقه خطر و اقدامات فوری نمایش داده شوند.
- Not Acute Cholecystitis—
- Suspected Acute Cholecystitis—
- Definite Acute Cholecystitis—
- Grade I (Mild)—
The Tokyo Guidelines 2018 for Acute Cholecystitis calculates assessing gastrointestinal disease severity, endoscopic intervention urgency, and rebleeding risk. Key inputs include murphys sign. Scores guide timing emergent endoscopy, initiating high-dose proton pump inhibitor infusions, or obtaining surgical consultation. This standardized assessment improves clinical decision safety and bedside patient management.
Clinical Guidelines & Evidence
Provides diagnostic criteria and severity grading for acute cholecystitis according to TG18 (Tokyo Guidelines 2018).
Clinical Indication
The Tokyo Guidelines 2018 for Acute Cholecystitis is indicated for bedside clinical practice to support Provides diagnostic criteria and severity grading for acute cholecystitis according to TG18 (Tokyo Guidelines 2018).. It assists healthcare providers in standardizing clinical assessment and therapeutic decision-making.
Target Population
Target population comprises Patients presenting with upper or lower gastrointestinal hemorrhage, acute pancreatitis, acute liver failure, or inflammatory bowel disease. Clinical application is indicated across Endoscopy suites, emergency GI triage, acute medical floors, and hepatology services.
Limitations & Contraindications
Initial hemoglobin values in hyperacute hemorrhage may falsely appear normal prior to complete extravascular-to-intravascular fluid equilibration.
Clinical Pearls & Action Plan
Aggressive intravascular volume resuscitation and blood product support must precede diagnostic or therapeutic endoscopy. Guideline pearl: Early laparoscopic cholecystectomy is recommended for all grades if patient can tolerate surgery.
Diagnostic: ≥1 item from Part A + ≥1 item from Part B (suspected) or Part A + Part B + Part C (definite). Severity: Grade III if any organ dysfunction, Grade II if any moderate criteria, Grade I if neither.
Input Parameters
| Name | Type | Required | Description |
|---|---|---|---|
| murphys_sign | string | Yes | Murphy's sign - Cessation of breathing during deep palpation of right upper quadrant |
| ruq_pain | string | Yes | Right upper abdominal quadrant mass, pain, or tenderness |
| fever | string | Yes | Fever (>38°C or >100.4°F) |
| elevated_crp | string | Yes | Elevated CRP (>3 mg/dL) |
| elevated_wbc | string | Yes | Elevated WBC count (>10,000/mm³) |
| imaging_findings | string | Yes | Imaging findings characteristic of acute cholecystitis (e.g. pericholecystic fluid, gallstones/debris) |
| cardiovascular_dysfunction | string | Yes | Cardiovascular dysfunction - Hypotension requiring treatment with dopamine ≥5 μg/kg per min or any dose of norepinephrine |
| neurological_dysfunction | string | Yes | Neurological dysfunction - Decreased level of consciousness |
| respiratory_dysfunction | string | Yes | Respiratory dysfunction - PaO2/FiO2 ratio <300 |
| renal_dysfunction | string | Yes | Renal dysfunction - Oliguria or creatinine >2.0 mg/dL |
| hepatic_dysfunction | string | Yes | Hepatic dysfunction - PT-INR >1.5 |
| hematological_dysfunction | string | Yes | Hematological dysfunction - Platelet count <100,000/mm³ |
| wbc_over_18000 | string | Yes | Elevated WBC count >18,000/mm³ |
| palpable_mass | string | Yes | Palpable tender mass in the right upper abdominal quadrant |
| duration_over_72h | string | Yes | Duration of complaints >72 hours |
| marked_inflammation | string | Yes | Marked local inflammation (gangrenous cholecystitis, pericholecystic abscess, hepatic abscess, biliary peritonitis, emphysematous cholecystitis) |
Score Interpretation & Guidance
| Range | Stage | Description |
|---|---|---|
| — | Not Acute Cholecystitis | Entry criteria not met |
| — | Suspected Acute Cholecystitis | Suspected diagnosis |
| — | Definite Acute Cholecystitis | Definite diagnosis |
| — | Grade I (Mild) | Mild acute cholecystitis |
| — | Grade II (Moderate) | Moderate acute cholecystitis |
| — | Grade III (Severe) | Severe acute cholecystitis |
Evidence-Based References (EBM)
- Yokoe M, Hata J, Takada T, Strasberg SM, Asbun HJ, Wakabayashi G, et al. Tokyo Guidelines 2018: diagnostic criteria and severity grading of acute cholecystitis (with videos). J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):41-54. doi: 10.1002/jhbp.515.DOI: 10.1002/jhbp.515
- Takada T, Strasberg SM, Solomkin JS, Pitt HA, Gomi H, Yoshida M, et al. TG13: Updated Tokyo Guidelines for the management of acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2013 Jan;20(1):1-7. doi: 10.1007/s00534-012-0566-y.DOI: 10.1007/s00534-012-0566-y
- Gomi H, Solomkin JS, Schlossberg D, Okamoto K, Takada T, Strasberg SM, et al. Tokyo Guidelines 2018: antimicrobial therapy for acute cholangitis and cholecystitis. J Hepatobiliary Pancreat Sci. 2018 Jan;25(1):3-16. doi: 10.1002/jhbp.518.DOI: 10.1002/jhbp.518